MOH Molina Healthcare Inc Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Lip 23, 2026MOH Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
MOH Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 23 maja 2011 | 3-for-2 | Naprzód |
O Molina Healthcare Inc Common Stock Przegląd firmy z Wikipedii
Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California. The company provides health insurance to individuals through government programs such as Medicaid and Medicare.
History
Molina Healthcare was founded in 1980 by C. David Molina, an emergency room physician in Long Beach, California. He had seen an influx of patients using the emergency room for common illnesses such as a sore throat or the flu because they were being turned away by doctors who would not accept Medi-Cal. Molina established his first primary care clinic with the goal of treating the lowest-income patients, regardless of their ability to pay.
Leadership
For twenty years, the company was run by Dr. Molina's son, J. Mario Molina, MD, a physician. He was the president and CEO of the company. John Molina, Mario's younger brother, was the CFO of Molina Healthcare. The two took over Molina's operations after their father died in 1996 and continued to expand the company. In May 2017 Dr. J. Mario Molina and John Molina were removed from their positions by the Board of Directors, who cited poor financial performance as the reason for the change in leadership. Though the board also discused their displeasure in the CEO and CFO criticising President Donald Trump.[3][4] In October 2017 the company announced Joseph Zubretsky, the former CFO of Aetna, as Molina Healthcare's president and CEO.
Clinics
The first Molina Medical clinic was opened in Wilmington, California in 1980. The company formerly operated clinics in Washington, New Mexico, Florida and Utah. The clinics were opened to provide health care to low-income families and individuals. In August 2017 Molina Healthcare announced it would close several clinics in Michigan, Florida, New Mexico, Wisconsin, and Utah.
Becoming HMO
Molina Healthcare has focused on government-paid healthcare programs such as SCHIP and Medicaid since it became a health maintenance organization in 1985. From 1985 to 1997, the company was based solely in California.
Expansion of health plans
1997: Molina Healthcare acquires Health Reach Family Health Care and enters the states of Utah and Michigan.
2000: Molina Healthcare enters the state of Washington.
2004: Molina Healthcare enters the state of New Mexico.
2005: Molina Healthcare becomes a health plan in Ohio.
2006: Molina Healthcare enters the state of Texas.
2007: Molina Healthcare enters Missouri.
2008: Molina Healthcare enters Florida.
2010: Molina Healthcare enters Wisconsin.
2012: Molina Healthcare enters Illinois.
2013: Molina Healthcare enters South Carolina by acquiring assets from Community Health Solutions.
2013: Molina Healthcare acquires New Mexico Lovelace Medicaid contract.
2014: Molina Healthcare acquires Florida Medicaid assets from First Coast Advantage.
2015: Molina Healthcare enters Chicago market, acquiring MyCare Chicago's Medicaid assets.
2015: Molina Healthcare enters Puerto Rico.
2015: Molina Healthcare of Washington is the first health care company in the state to cover "Virtual Urgent Care" services.
2015: Molina Healthcare acquires Medicaid assets of Integral Health Plan, Inc. in Florida.
2015: Molina Healthcare acquires Providence Human Services and Community Services from Providence Service Corporation and renames them Pathways.
2015: Molina Healthcare adds online access to behavioral health.
2015: Molina Healthcare acquires HealthPlus MIChild and Medicaid programs of Michigan.
2015: Molina Healthcare acquires assets of Loyola Physician Partners' Medicaid Program of Illinois.
2017: Molina Healthcare exits the individual Marketplace in Utah and Wisconsin.
2018: Molina Healthcare loses Medicaid contract with the state of New Mexico.
2018: Molina Healthcare sells Pathways to Altar Capital
2019: Molina Healthcare loses Medicaid contract with the state of Texas.
2020: Molina Healthcare acquires Passport Health Plan in Kentucky.
2021: Molina Healthcare acquires Magellan Complete Care line of business from Magellan Health, Inc. With this acquisition, Molina enters Arizona, Massachusetts, and Virginia.
2021: Molina Healthcare acquires Affinity Health Plan in New York.
2021: Molina Healthcare acquires Cigna's Medicaid contracts in Texas.
2023: Molina Healthcare enters Iowa.
2023: Molina Healthcare loses Medicad contract with the state of Indiana.
2024: Molina Healthcare loses Medicaid contracts with the states of Virginia and Florida.
Going public
Molina Healthcare filed with the Securities and Exchange Commission for an initial stock offering in December 2002 and went public in July 2003 with a stock offering of $102 million. The shares were priced at $17.50, and Molina raised approximately $124 million in the initial public offering. In its stock market debut, Molina sold 6.6 million shares at $20.30, making the company the third-best first day gainer of 2003. Molina Healthcare was the first company from Inc. Magazine's "Inner City 100" list to go public.
Entering the Medicare market
Molina Healthcare entered the Medicare market in 2006. The company currently offers Medicare health plan options in: Arizona, California, Florida, Idaho, Illinois, Kentucky, Massachusetts, Michigan, Nevada, New Mexico, New York, Ohio, South Carolina, Texas, Utah, Virginia, Washington and Wisconsin.
Entering MMIS market
Molina Healthcare acquired Unisys' health information management business in December 2010 to create Molina Medicaid Solutions (MMS). MMS has Medicaid Management Information Systems (MMIS) contracts with Idaho, Louisiana, Maine, New Jersey, West Virginia and the U.S. Virgin Islands. In Autumn 2018, Molina Healthcare, Inc. sold its Medicaid management information systems business, Molina Medicaid Solutions (MMS), to DXC Technology. MMS was a wholly owned subsidiary of Molina Healthcare at the time of sale.
Entering health insurance marketplace
In 2014, Molina Healthcare began offering Marketplace plans in nine states where it offered Medicaid health plans through State Facilitated Marketplaces and Federally Facilitated Marketplace. On November 16, 2016 the Seattle Times reported that about 11 million people currently get their coverage through the exchange. In August 2017 Molina announced it would stop offering plans on the health insurance marketplaces in Utah, Wisconsin, and Maine in 2018.
Dual eligible demonstration projects
Molina was selected to participate in dual eligible demonstration projects in California, Ohio, Illinois, Michigan, South Carolina and Texas to serve patients who are eligible for both Medicare and Medicaid.
Criticism and controversies
A 2023 report investigating "High Rates of Prior
Authorization Denials" reported that Molina Healthcare's Medicaid plans for financially vulnerable people had some of the highest denial percentages in the country. It was reported, that Molina Healthcare operated plans that denied medical care under requests for prior authorization of services in more than 25% of cases in 2019. About 2.7 million people were enrolled in these plans at the time, while another 8.4 million people were enrolled in plans with denial rates higher than average at 15-25%. Some plans had even higher denial rates, as their Illinois plan 41% of requests.
Philanthropy
In May 2022, MolinaCares presented a $100,000 grant to support Compass Health's Broadway Campus Redevelopment Project. The grant will aid funding of construction of a 72,000 square-foot, state-of-the-art facility that will expand community-based behavioural health care services and its workforce in northwest Washington.
In August 2026, MolinaCares awarded a grant of $150,000 to literacy non-profit Indy Reads, to launch a new program in health literacy, in partnership with Molina Healthcare.
Awards and recognition
Molina Healthcare was awarded the 2011 Alfred P. Sloan Award for Business Excellence in Workplace Flexibility. The award ranked Molina Healthcare in the top 20 percent of employers nationally in terms of its programs, policies and culture for creating an effective and flexible workplace. In 2006, Molina Healthcare was named among the 100 best corporate citizens by Business Ethics magazine. In 2005, Time magazine recognized Dr. J. Mario Molina, then CEO of Molina Healthcare, as one of the 25 most influential Hispanics in America.
The company ranked 155th on the 2021 Fortune 500 list of the largest United States corporations by revenue. The company ranked 126th on the 2023 Fortune 500 list of the largest United States corporations by revenue.
Other awards and recognition
2014: Milwaukee Journal Sentinel Recognizes Molina Healthcare of Wisconsin with a Top Workplace Award 2014
2014: Molina Healthcare of New Mexico voted Best Places to Work by Albuquerque Business First
2014: Molina Healthcare was one of 26 companies to participate in President Obama's SupplierPay 2014
2015: Molina Healthcare voted Top Ten Least Stressful Companies to Work for In America 2015
2015: Molina Healthcare ranked 301 in top Fortune 500 2015
2016: Molina Healthcare ranked 201 in top Fortune 500 2016
2017: Molina Healthcare ranked 156 in Fortune 500 2017
2023: Molina Healthcare of Kentucky awarded One of Kentucky's Best Places to Work
2023: Molina Healthcare recognized as one of America's Best-in-State Employers by Forbes
2023: Molina Healthcare recognized as one of Time's World's Best Companies of 2023
2023: Molina Healthcare recognized as one of Newsweek's Greatest Workplaces for Parents and Families 2023
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | MOH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 1053.0średnia z 5 lat ≈21.1 | ≈21.1 | 36.3 | Zawyżona wycena | |
| P/S (TTM) | 0.2średnia z 5 lat ≈0.5 | ≈0.5 | 0.7 | Niedowartościowany | |
| P/B (MRQ) | 2.4średnia z 5 lat ≈4.3 | ≈4.3 | 3.9 | Niedowartościowany | |
| EV / EBITDA (TTM) | 12.7średnia z 5 lat ≈7.0 | ≈7.0 | 16.1 | Niedowartościowany | |
| Cena / FCF (TTM) | 36.4średnia z 5 lat ≈14.4 | ≈14.4 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 27.0średnia z 5 lat ≈11.5 | ≈11.5 | · | · | |
| EV / Przychody (TTM) | 0.1średnia z 5 lat ≈0.3 | ≈0.3 | · | · | |
| EV / FCF (TTM) | 17.4średnia z 5 lat ≈10.3 | ≈10.3 | · | · | |
| Price / Tangible Book (Cena / Wartość księgowa materialna) | 5.3średnia z 5 lat ≈7.7 | ≈7.7 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | MOH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | 0.46%średnia z 5 lat ≈3.6% | ≈3.6% | 3.5% | Słaby | |
| Marża EBITDA (TTM) | 0.83%średnia z 5 lat ≈4.1% | ≈4.1% | 3.7% | Słaby | |
| Marża przed opodatkowaniem (TTM) | -0.01%średnia z 5 lat ≈3.2% | ≈3.2% | 2.8% | Słaby | |
| Marża Zysku Netto (TTM) | -0.02%średnia z 5 lat ≈2.4% | ≈2.4% | 2.9% | Słaby | |
| ROA (TTM) | -0.04%średnia z 5 lat ≈6.3% | ≈6.3% | 3.0% | Zgodnie z | |
| ROE (TTM) | -0.16%średnia z 5 lat ≈23.1% | ≈23.1% | 10.1% | Zgodnie z | |
| ROIC | 8.0%średnia z 5 lat ≈15.3% | ≈15.3% | 8.0% | Zgodnie z |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | MOH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.9średnia z 5 lat ≈0.7 | ≈0.7 | 0.7 | Wysokie zadłużenie | |
| Wskaźnik bieżący (MRQ) | 1.7średnia z 5 lat ≈1.5 | ≈1.5 | 1.7 | Zgodnie z | |
| Wskaźnik Szybkości (MRQ) | 1.6średnia z 5 lat ≈1.5 | ≈1.5 | 1.3 | Silna płynność | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.9średnia z 5 lat ≈0.7 | ≈0.7 | 0.7 | Wysokie zadłużenie |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | MOH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 11.8%średnia z 5 lat ≈19.1% | ≈19.1% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 12.4%średnia z 5 lat ≈15.5% | ≈15.5% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 18.5% | · | · | · | |
| EPS YoY | -56.3%średnia z 5 lat ≈2.3% | ≈2.3% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -60.0%średnia z 5 lat ≈0.79% | ≈0.79% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | -13.0%średnia z 5 lat ≈9.2% | ≈9.2% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | -4.5% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | -15.8%średnia z 5 lat ≈7.7% | ≈7.7% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | -6.9% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | MOH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 2.9średnia z 5 lat ≈2.6 | ≈2.6 | 2.4 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 13.3średnia z 5 lat ≈13.5 | ≈13.5 | 16.3 | Poniżej średniej | |
| Revenue / Employee (Przychody / pracownika) | ≈$2.4M | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 21, 2026 | $1.51 | $1.40 | 7.5% |
| 31 marca 2026 | $2.35 | $1.94 | 21.0% | |
| 31 grudnia 2025 | $-2.75 | $0.34 | -916.0% | |
| 30 września 2025 | $1.84 | $3.94 | -53.3% | |
| 30 czerwca 2025 | $5.48 | $5.85 | -6.3% | |
| 31 marca 2025 | $6.08 | $6.02 | 1.1% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Cost of Revenue | $39.49B | $34.43B | $28.67B | $27.18B | $23.70B | $15.82B | $13.90B | · | · | · | · | · | |
| Gross Profit | · | · | · | · | · | $2.48B | $2.30B | $2.52B | $1.81B | $1.73B | $1.53B | $1.00B | |
| SG&A Expense | $3.01B | $2.74B | $2.46B | $2.31B | $2.07B | $1.48B | $1.30B | $1.33B | $1.59B | $1.39B | $1.15B | $765M | |
| Operating Expenses | $44.65B | $38.94B | $32.50B | $30.80B | $26.75B | $18.34B | $15.79B | $17.76B | $20.44B | $17.48B | $13.79B | $9.47B | |
| Operating Income | $781M | $1.71B | $1.57B | $1.17B | $1.02B | $1.08B | $1.04B | $1.13B | $-555M | $306M | $387M | $193M | |
| Interest Expense | · | · | $109M | $110M | $120M | $102M | $87M | $115M | $118M | $101M | $66M | $57M | |
| Interest Income | · | · | · | $75M | $77M | $17M | $17M | $125M | $70M | $38M | $23M | $20M | |
| Other Non-op | · | · | $0 | $0 | $-25M | $-15M | $15M | $-17M | $61M | $0 | $1M | $-1M | |
| Pretax Income | $589M | $1.59B | $1.46B | $1.06B | $875M | $961M | $972M | $999M | $-612M | $205M | $322M | $135M | |
| Income Tax | $117M | $410M | $373M | $271M | $216M | $288M | $235M | $292M | $-100M | $153M | $179M | $73M | |
| Net Income | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| EPS (Basic) | $8.93 | $20.52 | $18.91 | $13.72 | $11.40 | $11.40 | $11.85 | $11.57 | $-9.07 | $0.93 | $2.75 | $1.33 | |
| EPS (Diluted) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 | |
| Shares (Basic) | 52,800,000 | 57,400,000 | 57,700,000 | 57,800,000 | 57,800,000 | 59,000,000 | 62,200,000 | 61,000,000 | 56,000,000 | 55,400,000 | 52,000,000 | 47,000,000 | |
| Shares (Diluted) | 52,900,000 | 57,700,000 | 58,100,000 | 58,500,000 | 58,600,000 | 59,900,000 | 64,200,000 | 67,000,000 | 56,000,000 | 56,000,000 | 56,000,000 | 48,000,000 | |
| EBITDA | $976M | $1.89B | $1.74B | $1.35B | $1.15B | $1.17B | $1.13B | $1.26B | $-377M | $488M | $513M | $327M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.25B | $4.66B | $4.85B | $4.01B | $4.44B | $4.15B | $2.45B | $2.83B | $3.19B | $2.82B | $2.33B | $1.54B | |
| Short-term Investments | $4.01B | $4.33B | $4.26B | $3.50B | $3.20B | $1.88B | $1.95B | $1.68B | $2.52B | $1.76B | $1.80B | $1.02B | |
| Receivables | $3.53B | $3.30B | $3.10B | $2.30B | $2.18B | $1.67B | $1.41B | $1.33B | $871M | $974M | $597M | $596M | |
| Prepaid Expense | $655M | $487M | $331M | $277M | $247M | $175M | $163M | $149M | $239M | $131M | $192M | $49M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $51M | |
| Current Assets | $12.44B | $12.77B | $12.54B | $10.08B | $10.06B | $7.88B | $5.97B | $6.46B | $7.51B | $5.99B | $5.31B | $3.20B | |
| PP&E (Net) | · | · | · | · | · | · | · | $241M | $342M | $454M | $393M | $341M | |
| PP&E (Gross) | $1.11B | $1.03B | $932M | $882M | $822M | $752M | $687M | $774M | $883M | $919M | $755M | $618M | |
| Accum. Depreciation | $875M | $806M | $729M | $695M | $632M | $577M | $530M | $533M | $541M | $465M | $362M | $277M | |
| Goodwill | $1.96B | $1.67B | $1.24B | $1.11B | $982M | $692M | $143M | $143M | $186M | $620M | $519M | $272M | |
| Intangibles | $237M | $267M | $208M | $275M | $270M | $249M | $29M | $47M | $69M | $140M | $122M | $89M | |
| Other Non-current Assets | $147M | $138M | $143M | $123M | $179M | $119M | $105M | $24M | $141M | $41M | $28M | $30M | |
| Total Assets | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Accounts Payable | $1.09B | $1.33B | $1.25B | $889M | $842M | $641M | $502M | $390M | $366M | $385M | $362M | $242M | |
| Current Liabilities | $7.37B | $7.90B | $8.17B | $6.86B | $7.05B | $4.96B | $3.27B | $4.25B | $5.56B | $4.57B | $3.82B | $2.17B | |
| Capital Leases | $56M | $68M | $85M | $77M | $99M | $42M | $48M | $197M | $198M | $198M | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $0 | $15M | $0 | $24M | |
| Other Non-current Liabilities | $173M | $120M | $124M | $104M | $140M | $119M | $90M | $44M | $61M | $42M | $37M | $34M | |
| Total Liabilities | $11.49B | $11.13B | $10.68B | $9.35B | $9.58B | $7.44B | $4.83B | $5.51B | $7.13B | $5.80B | $5.02B | $3.42B | |
| Long-term Debt | · | · | · | · | · | $2.13B | $1.25B | · | · | $1.65B | $1.41B | $690M | |
| Total Debt | $3.77B | $2.92B | $2.18B | $2.18B | $2.17B | $2.13B | $1.24B | $1.02B | $1.32B | $1.65B | $449M | $341.0K | |
| Retained Earnings | $3.60B | $4.09B | $3.89B | $2.80B | $2.40B | $1.86B | $1.78B | $1.01B | $298M | $810M | $758M | $615M | |
| AOCI | $15M | $-57M | $-82M | $-160M | $-5M | $37M | $4M | $-8M | $-5M | $-2M | $-4M | $-1M | |
| Stockholders' Equity | $4.07B | $4.50B | $4.21B | $2.96B | $2.63B | $2.10B | $1.96B | $1.65B | $1.34B | $1.65B | $1.56B | $1.01B | |
| Liabilities + Equity | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Shares Outstanding | 51,000,000 | 56,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 59,000,000 | 62,000,000 | 62,000,000 | 60,000,000 | 57,000,000 | 56,000,000 | 50,000,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $195M | $186M | $171M | $176M | $131M | $88M | $89M | $127M | $178M | $182M | $126M | $134M | |
| Stock-based Comp | $47M | $116M | $115M | $103M | $72M | $57M | $39M | $27M | $46M | $26M | $23M | $22M | |
| Deferred Tax | $43M | $53M | $-31M | $-66M | $-24M | $-19M | $10M | $-6M | $-94M | $22M | $-7M | $-2M | |
| Amort. of Intangibles | $91M | $82M | $85M | $77M | $49M | $15M | $18M | $21M | $31M | $32M | $17M | $18M | |
| Restructuring | · | · | · | · | · | · | · | $8M | $150M | · | · | · | |
| Other Non-cash | $-1.29B | $-890M | $316M | $-232M | $1.28B | $1.09B | $-448M | $-1.17B | $1.19B | $391M | $840M | $844M | |
| Operating Cash Flow | $-535M | $644M | $1.66B | $773M | $2.12B | $1.90B | $434M | $-314M | $804M | $673M | $1.12B | $1.06B | |
| CapEx | $101M | $100M | $84M | $91M | $77M | $74M | $57M | $30M | $86M | $176M | $132M | $115M | |
| Investing Cash Flow | $312M | $-464M | $-744M | $-790M | $-1.65B | $-400M | $-293M | $1.14B | $-1.06B | $-206M | $-1.42B | $-536M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $373M | $0 | |
| Stock Repurchased | $1.00B | $1.00B | $0 | $400M | $128M | $606M | $47M | $0 | $0 | · | $0 | $0 | |
| Net Stock Activity | $-1.00B | $-1.00B | $0 | $-400M | $-128M | $-606M | $-47M | · | $0 | $0 | $373M | $0 | |
| Financing Cash Flow | $-170M | $-347M | $-58M | $-441M | $-183M | $217M | $-559M | $-1.19B | $636M | $19M | $1.08B | $79M | |
| Net Change in Cash | $-393M | $-167M | $860M | $-458M | $283M | $1.72B | $-418M | $-364M | $378M | $486M | $790M | $603M | |
| Taxes Paid | $275M | $379M | $405M | $340M | $235M | $321M | $239M | $240M | $7M | $153M | $197M | $30M | |
| Free Cash Flow | $-636M | $544M | $1.58B | $682M | $2.04B | $1.82B | $370M | $-344M | $718M | $497M | · | · | |
| Levered FCF | · | · | $1.50B | $600M | $1.95B | $1.74B | $304M | $-425M | $619M | $471M | · | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 12.8% | 13.7% | 13.3% | 9.1% | 9.4% | 10.6% | · | |
| Operating Margin | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% | 5.5% | 6.2% | 6.0% | -2.8% | 1.7% | 2.7% | 2.0% | |
| Net Margin | 1.0% | 2.9% | 3.2% | 2.5% | 2.4% | 3.5% | 4.4% | 3.7% | -2.6% | 0.29% | 1.0% | 0.64% | |
| Pretax Margin | 1.3% | 3.9% | 4.3% | 3.3% | 3.1% | 5.0% | 5.8% | 5.3% | -3.1% | 1.1% | 2.3% | 1.4% | |
| EBITDA Margin | 2.1% | 4.7% | 5.1% | 4.2% | 4.1% | 6.0% | 6.7% | 6.7% | -1.9% | 2.7% | 3.6% | 3.4% | |
| ROA | 3.0% | 7.7% | 8.0% | 6.5% | 6.1% | 8.2% | 10.6% | 9.0% | -6.4% | 0.74% | 2.6% | 1.7% | |
| ROE | 10.9% | 25.4% | 27.0% | 26.4% | 25.6% | 33.2% | 40.9% | 47.4% | -34.3% | 3.2% | 11.1% | 6.5% | |
| ROIC | 8.0% | 17.1% | 18.3% | 17.0% | 16.0% | 17.9% | 24.8% | 30.0% | -17.5% | 2.4% | 8.6% | 8.8% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 | 1.6 | 1.8 | 1.5 | 1.4 | 1.3 | 1.4 | 1.5 | |
| Quick Ratio | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 | 1.6 | 1.8 | 1.4 | 1.2 | 1.2 | 1.2 | 1.5 | |
| Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 1.0 | 0.3 | 0.0 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 0.7 | · | · | |
| Interest Coverage | · | · | 14.4 | 10.7 | 8.5 | 10.6 | 12.0 | 9.8 | -4.7 | 3.0 | 5.9 | 3.4 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.9 | 2.7 | 2.5 | 2.6 | 2.6 | 2.4 | 2.4 | 2.4 | 2.5 | 2.5 | 2.6 | 2.6 | |
| Receivables Turnover | 13.3 | 12.7 | 12.6 | 14.3 | 14.4 | 12.6 | 12.3 | 17.2 | 21.6 | 22.6 | 23.8 | 21.6 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $79.78 | $80.29 | $72.67 | $51.10 | · | $35.53 | $31.61 | $26.56 | $22.28 | $28.93 | $27.80 | $20.32 | |
| Revenue / Share | $858.71 | $704.51 | $586.44 | $546.56 | $473.91 | $323.72 | $262.95 | $283.63 | $355.05 | $317.54 | $253.18 | $199.97 | |
| Cash Flow / Share | $-10.11 | $11.16 | $28.61 | $13.21 | $36.16 | $31.50 | $6.67 | $-4.71 | $14.36 | $12.02 | $20.09 | $21.93 | |
| Cash / Share | $83.29 | $83.25 | $83.59 | $69.07 | · | $70.41 | $39.55 | $45.58 | $53.10 | $49.46 | $41.59 | $30.95 | |
| EPS (TTM) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 19.3% | 6.6% | 15.1% | 43.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.4% | 13.5% | 20.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -56.3% | 8.8% | 38.5% | 20.4% | 0.18% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -13.0% | 22.0% | 18.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -4.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -60.0% | 8.1% | 37.8% | 20.2% | -2.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.8% | 21.4% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.9% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Net Income TTM | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| Market Cap | $8.85B | $16.30B | $20.96B | $19.15B | · | $12.55B | $8.41B | $7.21B | $4.60B | $3.09B | $3.37B | $2.66B | |
| Enterprise Value | $4.36B | $10.23B | $14.03B | $13.82B | · | $8.65B | $5.25B | $3.72B | $209M | $161M | $-314M | $104M | |
| P/E | 19.5 | 14.3 | 19.2 | 24.4 | 28.3 | 18.9 | 11.8 | 11.0 | -8.5 | 59.0 | 23.3 | 41.5 | |
| P/S | 0.2 | 0.4 | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | |
| P/B | 2.2 | 3.6 | 5.0 | 6.5 | · | 6.0 | 4.3 | 4.4 | 3.4 | 1.9 | 2.2 | 2.6 | |
| P / Tangible Book | 4.7 | 6.4 | 7.6 | 12.2 | · | 10.9 | · | · | · | · | · | · | |
| P / Cash Flow | -16.5 | 25.3 | 12.6 | 24.8 | · | 6.6 | 19.7 | -22.9 | 5.7 | 4.6 | 3.0 | 2.5 | |
| P / FCF | -13.9 | 30.0 | 13.3 | 28.1 | · | 6.9 | 22.7 | -20.9 | 6.4 | 6.2 | · | · | |
| EV / EBITDA | 4.5 | 5.4 | 8.0 | 10.2 | · | 7.4 | 4.6 | 3.0 | -0.6 | 0.3 | -0.6 | 0.3 | |
| EV / FCF | -6.9 | 18.8 | 8.9 | 20.3 | · | 4.8 | 14.2 | -10.8 | 0.3 | 0.3 | · | · | |
| EV / Revenue | 0.1 | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.2 | 0.0 | 0.0 | -0.0 | 0.0 | |
| Earnings Yield | 5.1% | 7.0% | 5.2% | 4.1% | 3.5% | 5.3% | 8.5% | 9.1% | -11.8% | 1.7% | 4.3% | 2.4% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.87B | $10.80B | $11.38B | $11.48B | $11.43B | $11.15B | $10.50B | $10.34B | $9.88B | $9.93B | $9.05B | $8.55B | $8.33B | $8.15B | $8.22B | $7.93B | |
| Cost of Revenue | $9.44B | $9.27B | $10.14B | $10.04B | $9.83B | $9.48B | $9.00B | $8.64B | $8.37B | $8.41B | $7.45B | $7.31B | $7.04B | $6.87B | $6.99B | $6.75B | |
| SG&A Expense | $724M | $779M | $795M | $729M | $711M | $774M | $665M | $676M | $691M | $711M | $645M | $608M | $618M | $591M | $629M | $560M | |
| Operating Expenses | $10.73B | $10.71B | $11.54B | $11.34B | $11.05B | $10.71B | $10.12B | $9.87B | $9.45B | $9.51B | $8.73B | $8.19B | $7.88B | $7.69B | $8.12B | $7.59B | |
| Operating Income | $145M | $83M | $-162M | $137M | $373M | $433M | $380M | $467M | $434M | $426M | $316M | $359M | $443M | $455M | $105M | $335M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $27M | · | $27M | $27M | $28M | · | $28M | |
| Interest Income | · | · | · | · | · | · | · | $20M | $21M | $22M | · | $20M | $19M | $21M | · | $19M | |
| Other Non-op | · | · | · | · | · | · | · | · | $-28M | $-27M | · | $-27M | $-27M | $-28M | · | $-28M | |
| Pretax Income | $91M | $29M | $-214M | $88M | $325M | $390M | $346M | $438M | $406M | $399M | $289M | $332M | $416M | $427M | $78M | $307M | |
| Income Tax | $31M | $15M | $-54M | $9M | $70M | $92M | $95M | $112M | $105M | $98M | $73M | $87M | $107M | $106M | $22M | $77M | |
| Net Income | $60M | $14M | $-160M | $79M | $255M | $298M | $251M | $326M | $301M | $301M | $216M | $245M | $309M | $321M | $56M | $230M | |
| EPS (Basic) | $1.19 | $0.27 | $-2.80 | $1.51 | $4.75 | $5.47 | $4.46 | $5.67 | $5.18 | $5.21 | $3.72 | $4.24 | $5.37 | $5.58 | $0.98 | $4.00 | |
| EPS (Diluted) | $1.19 | $0.27 | $-2.79 | $1.51 | $4.75 | $5.45 | $4.43 | $5.65 | $5.17 | $5.17 | $3.69 | $4.21 | $5.35 | $5.52 | $0.96 | $3.95 | |
| Shares (Basic) | 51,100,000 | 50,900,000 | · | 52,500,000 | 53,600,000 | 54,600,000 | · | 57,600,000 | 58,100,000 | 57,900,000 | · | 57,800,000 | 57,700,000 | 57,500,000 | · | 57,600,000 | |
| Shares (Diluted) | 51,300,000 | 51,000,000 | · | 52,500,000 | 53,700,000 | 54,800,000 | · | 57,700,000 | 58,200,000 | 58,300,000 | · | 58,100,000 | 57,900,000 | 58,000,000 | · | 58,300,000 | |
| EBITDA | $145M | $122M | · | $137M | $373M | $481M | · | $467M | $434M | $471M | · | $359M | $443M | $499M | · | $335M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.99B | $5.31B | $4.25B | $4.22B | $4.50B | $4.86B | $4.66B | $4.73B | $4.35B | $4.51B | $4.85B | $5.57B | $4.91B | $4.55B | $4.01B | $4.24B | |
| Short-term Investments | $3.93B | $3.94B | $4.01B | $4.23B | $4.31B | $4.44B | $4.33B | $4.48B | $4.35B | $4.42B | · | $4.11B | $3.89B | $3.81B | · | $3.64B | |
| Receivables | $3.48B | $3.42B | $3.53B | $3.52B | $3.87B | $3.49B | $3.30B | $3.26B | $3.23B | $3.35B | · | $2.46B | $2.38B | $2.54B | · | $2.22B | |
| Prepaid Expense | $528M | $655M | $655M | $590M | $438M | $472M | $487M | $408M | $399M | $381M | · | $332M | $260M | $259M | · | $391M | |
| Current Assets | $12.93B | $13.33B | $12.44B | $12.55B | $13.11B | $13.26B | $12.77B | $12.88B | $12.33B | $12.67B | · | $12.47B | $11.44B | $11.16B | · | $10.49B | |
| PP&E (Gross) | · | · | $1.11B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $875M | · | · | · | $806M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | $1.96B | · | · | · | $1.67B | · | · | · | $1.24B | · | · | · | $1.11B | · | |
| Intangibles | · | · | $237M | · | · | · | $267M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $140M | $146M | $147M | $142M | $148M | $163M | $138M | $132M | $136M | $134M | · | $125M | $118M | $119M | · | $186M | |
| Total Assets | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Accounts Payable | $1.14B | $1.16B | $1.09B | $1.12B | $1.11B | $1.12B | $1.33B | $1.22B | $973M | $1.11B | · | $1.09B | $857M | $787M | · | $818M | |
| Current Liabilities | $7.70B | $8.19B | $7.37B | $7.48B | $7.88B | $8.15B | $7.90B | $8.34B | $7.84B | $8.51B | · | $8.49B | $7.54B | $7.61B | · | $7.24B | |
| Capital Leases | · | · | $56M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $179M | $176M | $173M | $174M | $167M | $155M | $120M | $122M | $122M | $124M | · | $121M | $122M | $88M | · | $118M | |
| Total Liabilities | $11.83B | $12.31B | $11.49B | $11.51B | $11.61B | $12.08B | $11.13B | $10.99B | $10.34B | $11.02B | · | $10.99B | $10.04B | $10.08B | · | $9.75B | |
| Total Debt | $3.77B | $3.77B | · | $3.66B | $3.38B | $3.57B | · | $2.33B | $2.18B | $2.18B | · | $2.18B | $2.18B | $2.18B | · | $2.17B | |
| Retained Earnings | $3.68B | $3.62B | $3.60B | $3.76B | $4.16B | $3.90B | $4.09B | $4.33B | $4.49B | $4.19B | · | $3.67B | $3.43B | $3.12B | · | $2.94B | |
| AOCI | $-16M | $-7M | $15M | $9M | $-10M | $-28M | $-57M | $-9M | $-85M | $-85M | · | $-165M | $-146M | $-125M | · | $-185M | |
| Stockholders' Equity | $4.17B | $4.08B | $4.07B | $4.19B | $4.60B | $4.31B | $4.50B | $4.77B | $4.84B | $4.49B | $4.21B | $3.88B | $3.62B | $3.29B | $2.96B | $3.04B | |
| Liabilities + Equity | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Shares Outstanding | 52,000,000 | 52,000,000 | 51,000,000 | 51,000,000 | 54,000,000 | 54,000,000 | 56,000,000 | 57,000,000 | 59,000,000 | 59,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40M | $39M | $44M | $45M | $58M | $48M | $48M | $47M | $46M | $45M | $43M | $42M | $42M | $44M | $47M | $45M | |
| Stock-based Comp | $26M | $33M | $20M | $-3M | $3M | $27M | $18M | $30M | $32M | $36M | $27M | $33M | $30M | $25M | $23M | $23M | |
| Other Non-cash | · | $996M | · | · | · | $-183M | · | · | · | $-168M | · | · | · | $526M | · | · | |
| Operating Cash Flow | $-294M | $1.08B | $-298M | $-125M | $-302M | $190M | $-224M | $873M | $-219M | $214M | $-690M | $949M | $487M | $916M | $-212M | $254M | |
| CapEx | $30M | $27M | $-1M | $38M | $42M | $22M | $11M | $35M | $27M | $27M | $-5M | $26M | $31M | $32M | $10M | $31M | |
| Investing Cash Flow | $-30M | $11M | $230M | $77M | $128M | $-123M | $19M | $-48M | $53M | $-488M | $-25M | $-280M | $-137M | $-302M | $148M | $-347M | |
| Stock Repurchased | $0 | $0 | $0 | $500M | $0 | $500M | $500M | $500M | $0 | $0 | $0 | $0 | · | · | $200M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-500M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-4M | $-20M | $92M | $-220M | $-189M | $147M | $67M | $-364M | $12M | $-62M | $3M | $-6M | $10M | $-65M | $-183M | $10M | |
| Net Change in Cash | $-328M | $1.07B | $24M | $-268M | $-363M | $214M | $-138M | $461M | $-154M | $-336M | $-712M | $663M | $360M | $549M | $-247M | $-83M | |
| Free Cash Flow | · | $1.05B | · | · | · | $168M | · | · | · | $187M | · | · | · | $884M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $167M | · | · | · | $863M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 1.3% | 0.77% | · | 1.2% | 3.3% | 3.9% | · | 4.5% | 4.4% | 4.3% | · | 4.2% | 5.3% | 5.6% | · | 4.2% | |
| Net Margin | 0.55% | 0.13% | · | 0.69% | 2.2% | 2.7% | · | 3.1% | 3.0% | 3.0% | · | 2.9% | 3.7% | 3.9% | · | 2.9% | |
| Pretax Margin | 0.84% | 0.27% | · | 0.77% | 2.8% | 3.5% | · | 4.2% | 4.1% | 4.0% | · | 3.9% | 5.0% | 5.2% | · | 3.9% | |
| EBITDA Margin | 1.3% | 1.1% | · | 1.2% | 3.3% | 4.3% | · | 4.5% | 4.4% | 4.7% | · | 4.2% | 5.3% | 6.1% | · | 4.2% | |
| ROA | 0.37% | 0.09% | · | 0.50% | 1.6% | 1.9% | · | 2.1% | 2.1% | 2.1% | · | 1.8% | 2.4% | 2.5% | · | 1.9% | |
| ROE | 1.4% | 0.33% | · | 1.8% | 5.4% | 6.8% | · | 7.5% | 7.1% | 7.7% | · | 7.1% | 9.6% | 10.6% | · | 8.3% | |
| ROIC | 1.2% | 0.51% | · | 1.6% | 3.7% | 4.2% | · | 4.9% | 4.6% | 4.8% | · | 4.4% | 5.7% | 6.3% | · | 4.8% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.6 | · | 1.5 | 1.6 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.6 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 | |
| Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 15.8 | · | 13.3 | 16.4 | 16.2 | · | 12.0 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.6 | · | 0.7 | |
| Receivables Turnover | 3.0 | 3.1 | · | 3.4 | 3.2 | 3.3 | · | 3.6 | 3.5 | 3.4 | · | 3.7 | 3.6 | 3.5 | · | 3.8 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $80.21 | $78.46 | · | $82.18 | $85.24 | $79.81 | · | $83.68 | $82.08 | $76.15 | · | $66.88 | $62.43 | $56.69 | · | $52.43 | |
| Revenue / Share | $211.97 | $211.69 | · | $218.61 | $212.79 | $203.41 | · | $179.20 | $169.76 | $170.34 | · | $147.13 | $143.82 | $140.50 | · | $135.97 | |
| Cash Flow / Share | · | $21.22 | · | · | · | $3.47 | · | · | · | $3.67 | · | · | · | $15.79 | · | · | |
| Cash / Share | $95.87 | $102.19 | · | $82.76 | $83.31 | $89.93 | · | $83.02 | $73.80 | $76.49 | · | $95.95 | $84.66 | $78.52 | · | $73.14 | |
| EPS (TTM) | $0.18 | $3.74 | · | $16.14 | $20.28 | $20.70 | · | $19.68 | $18.24 | $18.42 | · | $16.04 | $15.78 | $14.68 | · | $14.33 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.52B | $45.08B | · | $44.55B | $43.41B | $41.87B | · | $39.20B | $37.41B | $35.85B | · | $33.25B | $32.63B | $32.35B | · | $31.16B | |
| Net Income TTM | $-7M | $188M | · | $883M | $1.13B | $1.18B | · | $1.14B | $1.06B | $1.07B | · | $931M | $916M | $855M | · | $839M | |
| Market Cap | $11.89B | $6.93B | · | $9.76B | $16.09B | $17.79B | · | $19.64B | $17.54B | $24.24B | · | $19.02B | $17.47B | $15.51B | · | $19.13B | |
| Enterprise Value | $6.75B | $1.45B | · | $4.98B | $10.65B | $12.07B | · | $12.76B | $11.02B | $17.48B | · | $11.52B | $10.85B | $9.33B | · | $13.42B | |
| P/E | 1270.6 | 35.6 | · | 11.9 | 14.7 | 15.9 | · | 17.5 | 16.3 | 22.3 | · | 20.4 | 19.1 | 18.2 | · | 23.0 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | |
| P/B | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Tangible Book | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Cash Flow | · | 6.4 | · | · | · | 93.6 | · | · | · | 113.3 | · | · | · | 16.9 | · | · | |
| EV / Revenue | 0.2 | 0.0 | · | 0.1 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| Earnings Yield | 0.08% | 2.8% | · | 8.4% | 6.8% | 6.3% | · | 5.7% | 6.1% | 4.5% | · | 4.9% | 5.2% | 5.5% | · | 4.3% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B |
| Marża Operacyjna % | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% |
| Zysk netto | $472M | $1.18B | $1.09B | $792M | $659M |
| Rozwodniony EPS | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 |
| Wskaźnik bieżący | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 |
| Wskaźnik Szybkości | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-636M | $544M | $1.58B | $682M | $2.04B |
Właściciele instytucjonalni (13F) 673 emitenci · $13.8B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 159 (+18 vs poprzedni kw.) | 68 (-75 vs poprzedni kw.) | 219 (+23 vs poprzedni kw.) | 181 (+8 vs poprzedni kw.) | +1.1M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $1 503 052 088 | 6 572 156 | 10,91% | Akcje |
| VANGUARD GROUP INC | $1 055 736 837 | 6 083 536 | 7,66% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $806 903 452 | 3 560 601 | 5,86% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $638 128 574 | 2 790 243 | 4,63% | Akcje |
| Capital World Investors | $586 138 203 | 2 562 913 | 4,26% | Akcje |
| Lingotto Investment Management LLP | $574 377 763 | 2 511 490 | 4,17% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $538 648 191 | 2 355 261 | 3,91% | Akcje |
| FMR LLC | $427 964 063 | 1 871 290 | 3,11% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $427 014 918 | 1 867 140 | 3,10% | Akcje |
| STATE STREET CORP | $401 475 303 | 1 755 467 | 2,91% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $318 659 985 | 1 393 338 | 2,31% | Akcje |
| GOLDMAN SACHS GROUP INC | $298 810 862 | 1 306 563 | 2,17% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $289 810 242 | 1 267 207 | 2,10% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $289 611 501 | 1 266 338 | 2,10% | Akcje |
| Capital Research Global Investors | $249 797 804 | 1 092 251 | 1,81% | Akcje |
| MORGAN STANLEY | $230 316 927 | 1 007 068 | 1,67% | Akcje |
| HARRIS ASSOCIATES L P | $218 980 250 | 957 500 | 1,59% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $204 005 369 | 891 772 | 1,48% | Akcje |
| 8 KNOTS MANAGEMENT, LLC | $198 942 438 | 1 146 378 | 1,44% | Akcje |
| MANNING & NAPIER ADVISORS LLC | $152 338 582 | 663 669 | 1,11% | Akcje |
| UBS Group AG | $142 749 967 | 624 180 | 1,04% | Akcje |
| Long Focus Capital Management, LLC | $139 507 000 | 610 000 | 1,01% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $131 512 792 | 575 045 | 0,95% | Akcje |
| TWO SIGMA ADVISERS, LP | $116 582 437 | 671 790 | 0,85% | Akcje |
| Invesco Ltd. | $116 332 600 | 508 669 | 0,84% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $115 548 617 | 505 241 | 0,84% | Akcje |
| NORTHERN TRUST CORP | $88 292 838 | 386 064 | 0,64% | Akcje |
| NORGES BANK | $87 054 426 | 380 649 | 0,63% | Akcje |
| Bank of New York Mellon Corp | $86 138 019 | 376 642 | 0,63% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $82 789 400 | 362 000 | 0,60% | Opcja sprzedaży |
| BNP PARIBAS FINANCIAL MARKETS | $82 559 556 | 360 995 | 0,60% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $75 497 758 | 330 117 | 0,55% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $72 051 935 | 315 050 | 0,52% | Akcje |
| BANK OF AMERICA CORP /DE/ | $71 479 956 | 312 549 | 0,52% | Akcje |
| Amundi | $59 944 786 | 262 111 | 0,44% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $57 795 692 | 252 714 | 0,42% | Akcje |
| Maple Rock Capital Partners Inc. | $55 642 710 | 243 300 | 0,40% | Akcje |
| Russell Investments Group, Ltd. | $53 133 740 | 232 165 | 0,39% | Akcje |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | $52 660 005 | 230 258 | 0,38% | Akcje |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $51 238 863 | 224 044 | 0,37% | Akcje |
| D. E. Shaw & Co., Inc. | $47 575 775 | 208 027 | 0,35% | Akcje |
| CITIGROUP INC | $47 390 070 | 207 215 | 0,34% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46 357 490 | 202 700 | 0,34% | Opcja kupna |
| REDWOOD CAPITAL MANAGEMENT, LLC | $45 740 000 | 200 000 | 0,33% | Akcje |
| DEUTSCHE BANK AG\ | $45 272 766 | 197 957 | 0,33% | Akcje |
| INVESTMENT HOUSE LLC | $44 310 854 | 193 751 | 0,32% | Akcje |
| JANE STREET GROUP, LLC | $43 224 300 | 189 000 | 0,31% | Opcja sprzedaży |
| Fiera Capital Corp | $43 130 075 | 188 588 | 0,31% | Akcje |
| Summit Street Capital Management, LLC | $41 630 489 | 182 031 | 0,30% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $41 211 511 | 180 199 | 0,30% | Akcje |
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Mary R. Molina Living Trust, Exempt Mary R. Molina Living Trust, Mary R. Molina Grantor Retained Annuity Trust 609/4, Mary R. Molina Grantor Retained Annuity Trust 609/7, Mary R. Molina Grantor Retained Annuity Trust 1209/3, Mary R. Molina Grantor Retained Annuity Trust 1209/4, Mary R. Molina Grantor Retained Annuity Trust 610/4, Mary R. Molina Grantor Retained Annuity Trust 610/5, Mary R. Molina Grantor Retained Annuity Trust 1210/4, Mary R. Molina Grantor Retained Annuity Trust 811/3, Mary R. Molina Grantor Retained Annuity Trust 812/3, Estate of Mary R. Molina, Dentino Family Trust, Curtis and Rosi Pedersen 2012 Trust, William Dentino, Curtis Pedersen ×3 zgłoszenia | 23 stycznia 2018 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 62 insiderów · 25 dyrektorzy generalni · 19 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Roman Kulich | Pres & CEO of Molina of MI | 22 sierpnia 2007 S | 5 734 | 0 | 0 | $0 |
| Gerald Landgraf | CEO/Pres of Molina of NM | 1 lipca 2005 A | · | 0 | 0 | $0 |
| Mark Lowell Keim | Chief Financial Officer | 1 marca 2026 A | 83 251 | 0 | 0 | $0 |
| Joseph W White CPA | Former Chief Financial Officer | 6 czerwca 2018 D | 48 390 | 0 | 0 | $0 |
| James Woys | Chief Operating Officer | 30 czerwca 2026 A | 90 178 | 0 | 0 | $0 |
| Terry Bayer | Chief Operating Officer | 2 lutego 2018 D | 28 730 | 0 | 0 | $0 |
| Debra Bacon | EVP, Medicaid | 1 lipca 2026 F | 21 636 | 0 | 0 | $0 |
| Jeff D. Barlow | Chief Legal Officer | 30 czerwca 2026 A | 67 313 | 0 | 1 | $-3 314 983 |
| Marc Russo | EVP, Health Plans | 7 sierpnia 2023 S | 37 093 | 0 | 0 | $0 |
| Pamela Sedmak | Executive Vice President | 1 marca 2020 F | 8 846 | 0 | 0 | $0 |
| Lisa A Rubino | Senior Vice President | 1 marca 2018 F | 25 084 | 0 | 0 | $0 |
| Keith Wilson | Chief Medical Officer | 30 czerwca 2017 A | 29 441 | 0 | 0 | $0 |
| Amir Desai | Chief Information Officer | 16 sierpnia 2010 S | 16 782 | 0 | 0 | $0 |
| Mark L Andrews ESQ | Exec. VP, General Counsel | 1 lipca 2010 F | 51 006 | 0 | 0 | $0 |
| Mary Martha Bernadett MD | Exec. V.P., Research | 5 grudnia 2008 J | 50 000 | 0 | 0 | $0 |
| Stephen T O'Dell | Regional Vice President | 7 sierpnia 2008 F | 16 199 | 0 | 0 | $0 |
| Lillis Ann Koontz | Regional Vice President | 30 czerwca 2008 A | 15 304 | 0 | 0 | $0 |
| George Kirk Olsen | VP, Molina Advantage | 29 czerwca 2007 A | 7 822 | 0 | 0 | $0 |
| Michael M Siegel | Chief Medical Officer | 1 marca 2007 A | 5 150 | 0 | 0 | $0 |
| Rick Click | Chief Information Officer | 1 marca 2007 A | 8 500 | 0 | 0 | $0 |
| Harvey A Fein | VP, Internal Auditing | 1 marca 2007 A | 8 713 | 0 | 0 | $0 |
| Joann Zarza-Garrido | VP, Compliance | 28 lutego 2007 S | 4 774 | 0 | 0 | $0 |
| William Bracciodieta | Former Chief Medical Officer | 16 lutego 2007 F | 5 000 | 0 | 0 | $0 |
| Sheila Shapiro | Exec. VP, Shared Services | 30 grudnia 2005 J | 12 564 | 0 | 0 | $0 |
| Jennings Patricia Dinsmore | VP Qual. Op. & Integration | 16 sierpnia 2004 S | 0 | 0 | 0 | $0 |
| Stephen H Lockhart | Dyrektor | 1 października 2026 A | 4 688 | 0 | 0 | $0 |
| Richard M Schapiro | Dyrektor | 1 października 2026 A | 12 615 | 0 | 1 | $-51 058 |
| Richard C Zoretic | Dyrektor | 1 października 2026 A | 9 693 | 1 | 0 | $100 128 |
| Leo P Grohowski | Dyrektor | 1 października 2026 A | 1 846 | 0 | 0 | $0 |
| Francis S Soistman JR | Dyrektor | 1 października 2026 A | 1 211 | 0 | 0 | $0 |
| Dale B Wolf | Dyrektor | 1 października 2026 A | 15 937 | 0 | 0 | $0 |
| Steven J Orlando | Dyrektor | 1 października 2026 A | 18 271 | 0 | 0 | $0 |
| Ronna Romney | Dyrektor | 1 października 2026 A | 18 173 | 0 | 1 | $-74 342 |
| Barbara L Brasier | Dyrektor | 1 października 2026 A | 6 122 | 0 | 0 | $0 |
| Daniel Cooperman | Dyrektor | 1 kwietnia 2025 A | 6 383 | 0 | 0 | $0 |
| Garrey Carruthers | Dyrektor | 1 kwietnia 2021 A | 5 265 | 0 | 0 | $0 |
| Charles Z Fedak | Dyrektor | 1 kwietnia 2019 A | 19 092 | 0 | 0 | $0 |
| John C Molina | Dyrektor | 20 lutego 2018 S | 372 930 | 0 | 0 | $0 |
| Frank E Murray MD | Dyrektor | 1 października 2017 A | 16 811 | 0 | 0 | $0 |
| Steven James | Dyrektor | 1 kwietnia 2016 A | 15 024 | 0 | 0 | $0 |
| John P Szabo JR | Dyrektor | 1 kwietnia 2015 A | 17 097 | 0 | 0 | $0 |
| Sally K Richardson | Dyrektor | 3 maja 2012 A | 47 537 | 0 | 0 | $0 |
| Wayne B Lowell | Dyrektor | 10 maja 2007 A | 10 011 | 0 | 0 | $0 |
| Ronald Cpa Dba Lossett | Dyrektor | 10 lutego 2004 A | · | 0 | 0 | $0 |
| MARY R MOLINA LIVING TRUST | Posiadacz 10% | 14 grudnia 2009 J | 2 137 134 | 0 | 0 | $0 |
| MOLINA MARITAL TRUST | Posiadacz 10% | 22 czerwca 2006 S | 2 926 907 | 0 | 0 | $0 |
| Maurice Hebert | · | 14 maja 2026 S | 12 815 | 0 | 1 | $-114 930 |
| Joseph M Zubretsky | · | 1 marca 2026 A | 99 015 | 0 | 0 | $0 |
| Thomas L Tran | · | 24 maja 2021 F | 29 775 | 0 | 0 | $0 |
| Norman Nichols | · | 8 sierpnia 2018 S | 47 415 | 0 | 0 | $0 |
| Harold Gooch | · | 30 czerwca 2018 A | 7 063 | 0 | 0 | $0 |
| Mario J Molina MD | · | 11 grudnia 2017 S | 61 125 | 0 | 0 | $0 |
| James W Howatt | · | 19 marca 2010 S | 34 081 | 0 | 0 | $0 |
| Curtis Pedersen | · | 5 listopada 2009 G | 1 200 | 0 | 0 | $0 |
| Josephine M Molina | · | 6 sierpnia 2008 J | 345 701 | 0 | 0 | $0 |
| Janet M Watt | · | 6 sierpnia 2008 J | 284 641 | 0 | 0 | $0 |
| Josephine M Battiste | · | 6 sierpnia 2008 J | 345 701 | 0 | 0 | $0 |
| Zarina Sparling | · | 21 lutego 2008 M | 9 380 | 0 | 0 | $0 |
| Mary R Molina | · | 27 września 2006 J | 0 | 0 | 0 | $0 |
| George S Goldstein PHD | · | 11 maja 2006 M | 0 | 0 | 0 | $0 |
| Richard A Helmer MD | · | 30 czerwca 2005 J | 1 908 | 0 | 0 | $0 |
| David W Erickson | · | 2 grudnia 2004 M | 0 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 74 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| SOVF · Elevation Series Trust | 4,23% | 18 894 NS | 31 lipca 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 1,71% | 120 017 SH | 2 października 2026 | Dziennie |
| RFV · Invesco Exchange-Traded Fund Trust | 1,66% | 29 907 SH | 2 października 2026 | Dziennie |
| IHF · iShares Trust | 1,53% | 100 080 SH | 11 września 2026 | Dziennie |
| VIOV · VANGUARD ADMIRAL FUNDS | 1,28% | 110 553 SH | 19 sierpnia 2026 | Dziennie |
| PIZ · Invesco Exchange-Traded Fund Trust … | 1,17% | 105 488 SH | 2 października 2026 | Dziennie |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0,76% | 5 983 000 | 2 października 2026 | Dziennie |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,64% | 182 154 SH | 19 sierpnia 2026 | Dziennie |
| FFLV · FIDELITY COVINGTON TRUST | 0,41% | 343 NS | 31 lipca 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,40% | 6 790 NS | 31 lipca 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,31% | 7 103 SH | 2 października 2026 | Dziennie |
| DFAT · Dimensional ETF Trust | 0,27% | 198 247 NS | 31 lipca 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,26% | 8 610 NS | 31 lipca 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,25% | 758 589 SH | 19 sierpnia 2026 | Dziennie |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 22 626 NS | 31 lipca 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,22% | 765 NS | 31 lipca 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,20% | 3 918 NS | 31 lipca 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,18% | 156 577 SH | 19 sierpnia 2026 | Dziennie |
| ESML · iShares Trust | 0,17% | 23 899 SH | 11 września 2026 | Dziennie |
| IYH · iShares Trust | 0,17% | 30 059 SH | 11 września 2026 | Dziennie |
| DFSV · Dimensional ETF Trust | 0,16% | 67 624 NS | 31 lipca 2026 | N-PORT |
| ISCG · iShares Trust | 0,16% | 7 446 SH | 11 września 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,15% | 24 870 NS | 31 lipca 2026 | N-PORT |
| SMMD · iShares Trust | 0,14% | 27 458 SH | 11 września 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,14% | 1 195 007 SH | 19 sierpnia 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,13% | 597 850 SH | 19 sierpnia 2026 | Dziennie |
| IWS · iShares Trust | 0,10% | 77 233 SH | 11 września 2026 | Dziennie |
| WSML · iShares Trust | 0,10% | 3 305 SH | 11 września 2026 | Dziennie |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,09% | 4 929 SH | 2 października 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,09% | 68 863 NS | 31 lipca 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 3 775 SH | 2 października 2026 | Dziennie |
| IWR · iShares Trust | 0,08% | 210 604 SH | 11 września 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,06% | 35 013 SH | 2 października 2026 | Dziennie |
| EMGF · iShares, Inc. | 0,06% | 15 805 SH | 11 września 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,05% | 1 409 NS | 31 lipca 2026 | N-PORT |
| EMXC · iShares, Inc. | 0,05% | 162 911 SH | 11 września 2026 | Dziennie |
| DFSU · Dimensional ETF Trust | 0,04% | 5 157 NS | 31 lipca 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,03% | 305 NS | 31 lipca 2026 | N-PORT |
| IUSV · iShares Trust | 0,03% | 45 470 SH | 11 września 2026 | Dziennie |
| IEMG · iShares, Inc. | 0,03% | 689 771 SH | 11 września 2026 | Dziennie |
| EEM · iShares, Inc. | 0,03% | 131 827 SH | 11 września 2026 | Dziennie |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 31 058 SH | 19 sierpnia 2026 | Dziennie |
| IWD · iShares Trust | 0,03% | 114 206 SH | 11 września 2026 | Dziennie |
| DFUV · Dimensional ETF Trust | 0,03% | 20 443 NS | 31 lipca 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,03% | 52 472 SH | 11 września 2026 | Dziennie |
| TILT · FlexShares Trust | 0,02% | 2 686 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 1 655 258 SH | 19 sierpnia 2026 | Dziennie |
| VWO · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 868 836 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 8 548 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 4 354 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,02% | 11 634 SH | 19 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,02% | 45 023 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 2 946 NS | 31 lipca 2026 | N-PORT |
| IXUS · iShares Trust | 0,02% | 126 782 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,01% | 14 718 SH | 11 września 2026 | Dziennie |
| IWB · iShares Trust | 0,01% | 35 396 SH | 11 września 2026 | Dziennie |
| IYY · iShares Trust | 0,01% | 2 168 SH | 11 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,01% | 15 184 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 67 059 SH | 11 września 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,01% | 8 285 NS | 31 lipca 2026 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0,01% | 531 000 SH | 11 września 2026 | Dziennie |
| VOXP · Advisors Series Trust | 0,01% | 3 NS | 31 lipca 2026 | N-PORT |
| ACWX · iShares Trust | 0,01% | 16 724 SH | 11 września 2026 | Dziennie |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 910 737 SH | 19 sierpnia 2026 | Dziennie |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 145 760 SH | 19 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 89 282 SH | 19 sierpnia 2026 | Dziennie |
| VYMI · VANGUARD WHITEHALL FUNDS | 0,01% | 68 906 SH | 19 sierpnia 2026 | Dziennie |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2 303 SH | 2 października 2026 | Dziennie |
| ACWI · iShares Trust | 0,00% | 8 307 SH | 11 września 2026 | Dziennie |
| IJH · iShares Trust | · | 1 828 162 SH | 11 września 2026 | Dziennie |
| IJJ · iShares Trust | · | 265 658 SH | 21 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | · | 2 352 SH | 11 września 2026 | Dziennie |
| ISCV · iShares Trust | · | 6 481 SH | 11 września 2026 | Dziennie |
| SMMV · iShares Trust | · | 4 872 SH | 1 września 2026 | Dziennie |
MOH Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
12-miesięczny cel cenowy
17 analityków · 2026-09-30Średnia cel $209.12 +10,3%
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.